[go: up one dir, main page]

ES2167385T3 - Medicamentos de accion antihiperglicemica. - Google Patents

Medicamentos de accion antihiperglicemica.

Info

Publication number
ES2167385T3
ES2167385T3 ES95109812T ES95109812T ES2167385T3 ES 2167385 T3 ES2167385 T3 ES 2167385T3 ES 95109812 T ES95109812 T ES 95109812T ES 95109812 T ES95109812 T ES 95109812T ES 2167385 T3 ES2167385 T3 ES 2167385T3
Authority
ES
Spain
Prior art keywords
antihiperglicemic
action drugs
drugs
action
profilaxis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95109812T
Other languages
English (en)
Inventor
Elbert Dr Kaan
Dieter Dr Ziegler
Reinhard Dr Bruckner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Products GmbH
Original Assignee
Solvay Pharmaceuticals GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharmaceuticals GmbH filed Critical Solvay Pharmaceuticals GmbH
Application granted granted Critical
Publication of ES2167385T3 publication Critical patent/ES2167385T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Dental Preparations (AREA)
  • Fats And Perfumes (AREA)

Abstract

SE DESCRIBE LA UTILIZACION DE MOXONIDINA Y SUS SALES DE ADICION ACIDA TOLERABLES FISIOLOGICAMENTE PARA LA ELABORACION DE PREPARACIONES FARMACEUTICAS PARA TRATAMIENTO Y/O PROFILAXIS DE HIPERGLICEMIA.
ES95109812T 1994-07-01 1995-06-23 Medicamentos de accion antihiperglicemica. Expired - Lifetime ES2167385T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4423177A DE4423177A1 (de) 1994-07-01 1994-07-01 Antihyperglykämisch wirksame Arzneimittel

Publications (1)

Publication Number Publication Date
ES2167385T3 true ES2167385T3 (es) 2002-05-16

Family

ID=6522064

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95109812T Expired - Lifetime ES2167385T3 (es) 1994-07-01 1995-06-23 Medicamentos de accion antihiperglicemica.

Country Status (23)

Country Link
US (1) US5712283A (es)
EP (1) EP0689837B1 (es)
JP (1) JP3841846B2 (es)
KR (1) KR100366130B1 (es)
CN (1) CN1092961C (es)
AT (1) ATE210444T1 (es)
AU (1) AU691580B2 (es)
CA (1) CA2152998C (es)
CZ (1) CZ287563B6 (es)
DE (2) DE4423177A1 (es)
DK (1) DK0689837T3 (es)
DZ (1) DZ1894A1 (es)
ES (1) ES2167385T3 (es)
FI (1) FI117374B (es)
HU (1) HU226946B1 (es)
IL (1) IL113411A (es)
NO (1) NO307029B1 (es)
NZ (1) NZ270990A (es)
PT (1) PT689837E (es)
RU (1) RU2145857C1 (es)
SK (1) SK282227B6 (es)
UA (1) UA27954C2 (es)
ZA (1) ZA954691B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0812197A2 (en) * 1995-02-28 1997-12-17 Beiersdorf-Lilly GmbH Use of moxonidine for the treatment of atherosclerosis
HUP0003885A2 (hu) * 1996-06-06 2001-04-28 Eli Lilly And Co. Készítmény pangásos szívelégtelenség kezelésére
NO980546L (no) * 1997-02-11 1998-08-12 Lilly Co Eli Farmas°ytiske midler
DE19722322A1 (de) * 1997-05-28 1998-12-03 Solvay Pharm Gmbh Nephroprotektives Arzneimittel
US6066643A (en) * 1997-10-17 2000-05-23 Eli Lilly And Company Potentiation of pharmaceuticals
US6897019B1 (en) * 1998-04-17 2005-05-24 Tufts College Methods for treating and preventing insulin resistance and related disorders
AU2727400A (en) * 1999-01-29 2000-08-18 Eli Lilly And Company Moxonidine salts
DE19911371A1 (de) 1999-03-15 2000-09-21 Solvay Pharm Gmbh Arzneimittel zur Behandlung von funktionellen Störungen und Erkrankungen der unteren Darmwege, insbesondere von damit einhergehenden abdominalen visceralen Schmerzen
PL372695A1 (en) * 2002-06-19 2005-07-25 Solvay Pharmaceuticals Gmbh Medicament for the treatment of diseases requiring inhibition or a reduction in the activity of ph value-regulating bicarbonate transporter proteins
WO2005039639A2 (en) * 2003-10-10 2005-05-06 Solvay Pharmaceuticals Gmbh Pharmaceutical composition comprising a selective i1 imidazoline receptor agonist and an angiotensin ii receptor blocker
RU2542462C2 (ru) * 2013-06-28 2015-02-20 Андрей Владиславович Струтынский Способ коррекции кризового течения гипертонической болезни и абдоминального ожирения

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2849537C2 (de) * 1978-11-15 1983-03-17 Beiersdorf Ag, 2000 Hamburg Substituierte 5-(2-Imidazolin-2-yl)-aminopyrimidine, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
US4323570A (en) * 1978-11-15 1982-04-06 Beiersdorf Aktiengesellschaft Substituted aminopyrimidines
FR2669927B1 (fr) * 1990-11-29 1994-04-08 Adir Cie Nouveaux derives de guanidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
DZ1894A1 (fr) 2002-02-17
ATE210444T1 (de) 2001-12-15
EP0689837A2 (de) 1996-01-03
KR100366130B1 (ko) 2003-03-26
NO952624D0 (no) 1995-06-30
IL113411A (en) 1999-07-14
AU1775795A (en) 1996-01-18
FI117374B (fi) 2006-09-29
JPH0840906A (ja) 1996-02-13
IL113411A0 (en) 1995-07-31
HUT72599A (en) 1996-05-28
CA2152998C (en) 2002-09-03
CZ287563B6 (en) 2000-12-13
KR960003729A (ko) 1996-02-23
SK282227B6 (sk) 2001-12-03
CN1122224A (zh) 1996-05-15
EP0689837A3 (de) 1996-06-05
DK0689837T3 (da) 2002-03-11
HU9501900D0 (en) 1995-08-28
CN1092961C (zh) 2002-10-23
SK74995A3 (en) 1996-05-08
JP3841846B2 (ja) 2006-11-08
RU2145857C1 (ru) 2000-02-27
ZA954691B (en) 1996-01-29
UA27954C2 (uk) 2000-10-16
NO952624L (no) 1996-01-02
US5712283A (en) 1998-01-27
FI953256A0 (fi) 1995-06-30
DE59509928D1 (de) 2002-01-24
CA2152998A1 (en) 1996-01-02
PT689837E (pt) 2002-04-29
NZ270990A (en) 1997-06-24
DE4423177A1 (de) 1996-01-04
FI953256L (fi) 1996-01-02
NO307029B1 (no) 2000-01-31
CZ139395A3 (en) 1996-01-17
EP0689837B1 (de) 2001-12-12
AU691580B2 (en) 1998-05-21
HU226946B1 (en) 2010-03-29

Similar Documents

Publication Publication Date Title
HUP0002373A2 (hu) Glükagon antagonisták/inverz agonisták és ezeket tartalmazó gyógyászati készítmények
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
MX9307885A (es) Aplicacion de la carbamzaepina y oxcarbazepian para la obtencion de medicamentos para el tratamiento de la enfermedad de parkinson y los sindromes parkinsonianos.
ES2159382T3 (es) Compuestos estilbenicos con grupo adamantilo, composiciones que los contienen y utilizaciones.
SE8804629D0 (sv) New therapeutically active compounds
MX9801596A (es) Composiciones aliviadoras del prurito, cosmeticas y farmaceuticas o ambas.
ES2058651T3 (es) Uso derivados de guanidina para la fabricacion de un medicamento con actividad antagonista de npy.
ES2167385T3 (es) Medicamentos de accion antihiperglicemica.
FI895520A0 (fi) Anti-aterosklerotiska diaryl foereningar.
ATE173923T1 (de) Oralanzuwendende flüssige arzneizubereitung enthaltend 2-(4-isobutylphenyl)propionsäure
ATE213633T1 (de) Lamotrigin haltiges arzneimittel
ES2064166T3 (es) Composiciones conteniendo propionato de fluticasona y oxiconazol o sus sales para administracion topica.
HUP9700806A2 (hu) Tianeptin-nátriumsó nyújtott felszabadulását biztosító, szájon át beadható mátrix tabletta és eljárás előállítására
FR2731907B1 (fr) Composition dermatologique et/ou cosmetique depigmentante et utilisation dans une methode cosmetique
ES2151922T3 (es) Uso de aspirina para la fabricacion de un medicamento para mejorar la perfusion sanguinea en el utero.
NO995838L (no) Nye heteroetynylenforbindelser og farmasoeytiske og kosmetiske preparater inneholdende de samme
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
RU94002476A (ru) Лекарственное средство
BR9812531A (pt) Combinação de componentes, preparação farmacêutica, produção desta, e, uso da combinação ou da preparação farmacêutica
AR059965A2 (es) Uso de 8,9-dehidroestrona para la preparacion de un medicamento antioxidante
DE3751597D1 (de) Verwendung von 15-Deoxyspergualin als Arzneimittel.
ES2178798T3 (es) Medicamento nefroprotector.
DE69228686D1 (de) Topisch anzuwendendes arzneimittel enthaltend penciclovir
HUP9603327A2 (hu) Helyileg alkalmazható készítmény peptidszerű gyógyhatású vegyületek élő szervezetbe vitelére
NO953003L (no) Anvendelse av ifenprodil og diastereoisomerer derav for fremstilling av medisinske preparater